---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-003756"
form_type: "8-K"
ticker: "BFRI"
cik: "0001858685"
company_name: "Biofrontera Inc."
filed_at: "2024-01-25T23:59:59+00:00"
generated_at: "2026-06-06T18:31:54.809746+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Biofrontera gets Nasdaq extension until May 20, 2024 to regain compliance

## Summary
- Nasdaq granted a 180-day extension from Nov 22, 2023 (new deadline May 20, 2024) to regain compliance.
- Company had submitted a compliance plan on January 8, 2024, after initial delisting notice.
- Must demonstrate compliance with Nasdaq continued listing requirements by the extended deadline.

## SEC filing metadata
- accession: 0001493152-24-003756
- form_type: 8-K
- ticker: BFRI
- cik: 0001858685
- company_name: Biofrontera Inc.
- filed_at: 2024-01-25T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1858685/000149315224003756/0001493152-24-003756-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1858685/000149315224003756/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-003756
- JSON: https://secwatch.observer/filing/0001493152-24-003756.json
- Plain text: https://secwatch.observer/filing/0001493152-24-003756.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.